LSI Europe

Vektor Medical, Inc. is advancing care for arrhythmia patients by unlocking insights contained in a standard ECG. Cardiac arrhythmias cause 10% of global deaths and over 25% of adults over 40 will develop a serious arrhythmia. Untreated arrhythmias not only raise the risk of death but are also associated with serious co-morbidities such as stroke and dementia. The vMap system uses advanced computational models and machine learning algorithms to analyze electrocardiogram (ECG) data. The platform can map the heart’s electrical activity in a matter of minutes, aiding in the precise localization of arrhythmias and improving the efficiency of cardiac ablation procedures. By offering an FDA-cleared, non-invasive alternative, vMap has the potential to reduce patient risks, minimize procedural time, and optimize treatment outcomes. Want to learn more about Vektor Medical? Catch Robert J. Krummen’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Don’t miss our next event! LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

While more than 6 million new abdominal and lung cancers are diagnosed every year, Quantum Surgical’s purpose is to offer an innovative approach to cancer treatment, accessible to a wider population, allowing more patients to benefit from state-of-the-art, more targeted, and less invasive treatments. To achieve this goal, Quantum Surgical has developed the Epione® robot, dedicated to the curative and early treatment of cancers. It enables physicians to treat tumors that are inoperable or particularly difficult to reach, due to their size or their location, at an early stage without surgical intervention, in a simple and effective manner. The journey began with a focus on lung, liver, kidney, and pancreatic cancers—some of the leading causes of cancer-related deaths worldwide. Epione® has already received CE marking for use in the treatment of abdomen and lung tumors, and FDA clearance for abdominal tumor ablations. Want to learn more about Quantum Surgical? Catch Laetitia Messner’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Don’t miss our next event! LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

Earlier this month, Positrigo achieved a significant milestone with the CE Mark approval for its NeuroLF® system, following recent FDA clearance. This makes NeuroLF® the first of its kind to secure regulatory approval in both the U.S. and Europe. The NeuroLF® is an ultra-compact Positron Emission Tomography (PET) system designed to assist in the diagnosis and monitoring of brain disorders, including Alzheimer’s, brain tumors, epilepsy, Parkinson’s, and more. Positrigo's innovation aims to make advanced brain imaging more accessible, offering earlier diagnoses and better patient outcomes. Want to learn more about Positrigo? Catch Jannis Fischer’s full video presentation from LSI Europe ‘24 on our website and YouTube channel. PS: Don’t miss our next event! LSI USA ‘25 will be held March 17th-21st in Dana Point, California. Apply today on our website.

“We wanted to be able to leverage both the expertise we had in the United States and the expertise that existed in Europe. It was a match made in heaven.” Vektor Medical CEO Robert J. Krummen shared his insights on the importance of building cross-border relationships for investors and innovators alike as part of a recent panel discussion at LSI Europe ’24. You can view the entire discussion, “Building Syndicates of Cross-Border Investors in Medtech Companies,” and hear more from Rob and other panelists below: Ashley Seehusen (Moderator), Venture Partner SANTÉ Ventures & CEO at Santé Accel C David Adair MD, MBA, FACOG, FASH, C-EFM, Managing Partner & Co-Founder, Solas BioVentures Dr. Luc Marengere, Managing Partner, TVM Capital Life Science Alexander Goemans, CFO, Xeltis #medtech #lsieurope24 #innovation #lsialumni

Deals like this are one of the many reasons we do what we do. Congratulations to Lymphatica Medtech on your Series B fundraise!

More highlights from Day 2! The afternoon brought us 7 more engaging panels featuring: AI Infrastructure and the Future of Imaging • Natasha Allen (Moderator) — Foley & Lardner • Sahirzeeshan (Sahir) Ali — Modi Ventures • Imran Hamid, MD — LifeArc Ventures • Soyoung Park — 1004 Venture Partners • Vishal Gulati — Recode Ventures AgeTech: Headwinds, Tailwinds, and Unmet Needs for the Global Aging Population • Henry Peck (Moderator) — LSI • Soyoung Park — 1004 Venture Partners • Nicole J Walker — Multiple Companies • Dr. Gal Noyman - Veksler — LionBird Investors That Pass: An Open Dialogue on Investment Mandates and Definitions of Success • Fernando Pacheco (Moderator) — Endeavour Vision • Alexei Mlodinow — SIA (Acquired by Integra LifeSciences) • Diana Saraceni — Panakes Partners • Dr. Irit Yaniv — Almeda Ventures Business Model Design in Digital Health: Creating, Delivering, and Capturing Value While Defending Your Business • Joe Mullings (Moderator) — The Mullings Group • Bryn Davies — Proximie • Boaz Lifschitz — Peregrine Ventures • Addie H. — HAVENTURE An Open Discussion on the State of Women’s Health • Yahel Halamish (Moderator) — Nina Capital • Sharon Handelman-Gotlib — Shela Health • Regina Atim, PharmD, MBA, BCMAS, CPHIMS — Clinicians Touch Allyve • Andrew Pieprzyk — Hologic What Matters to Corporate VCs in 2024? • Ryan Roberts (Moderator) — Veranex • Dan Sheehan — Medtronic • Murielle Thinard McLane — Intuitive Ventures • Colin Morrison — Boston Scientific • Nir G. — Mayo Clinic A huge thank you to all our panelists for delivering such engaging and insightful sessions!

The final day of presentations is underway! Thank you to all the innovators who have taken the stage so far to share their stories and groundbreaking technologies. We're excited for another action-packed day, with over 70 more presentations lined up. Day 3 here we go!

Highlights from Day 2-morning panels! We hit the ground running with four engaging panels this morning, featuring: Prosperity in Adversity: Doubling Down on Smart Investments in Uncertain Times • Ido Hadari (Moderator) — Hadari Consulting • Rafael Beyar — ALIVE Israel HealthTech Fund • Assaf Barnea — Sanara Ventures • Sharon Handelman-Gotlib —Shela Health • Daniel Allen, PhD — Unorthodox Ventures Amber Therapeutics: $100M Series A, and the Future of Neuromodulation for Mixed Urinary Incontinence • Henry Peck (Moderator) — LSI • Aidan Crawley — Amber Therapeutics • Caroline Gaynor — Lightstone Ventures • Murielle Thinard McLane — Intuitive Ventures • Liliane Chamas, PhD — Oxford Science Enterprises Medtech’s Conundrum: Where Will Capital and Liquidity Come From? • Bill Little — Orchestra BioMed • Michael Wasserman — Elevage Medical Technologies • Alexander Schmitz — Endeavour Vision • David Kereiakes — Windham Capital Partners • Diana Saraceni — Panakes Partners Raising Capital from Family Offices • Alexei Mlodinow — SIA • Tyler Wanke — Wanke Family Office • John Slump — Atraverse Medical • Pablo Prieto — CG Health Ventures • Marie-Louise Little — TW Medical A/S (Family Office) We’re about halfway through LSI Europe ‘24 - Still much more on the way. #LSIEurope24

More highlights from Day 1! The afternoon brought us 6 more engaging panels featuring: Medtech Financing in Europe: Current State and Insights from Successful Raises • Roger Brooks — Rbooks Group • Dave Marver — Onward Medical • Aidan Crawley — Amber Therapeutics • Sandrine Cailleteau — RBC Capital Markets Training and Supporting the Next Wave of Entrepreneurs Through Mentorship and Capital • Joe Mullings — The Mullings Group • Adam Rosenwach — Deerfield Catalyst • Dr. Gal Noyman - Veksler — LionBird • Shai Policker — MEDX Xelerator • Ashley Seehusen — SANTÉ The EU AI Act: Implications for Startups, Innovation, and Investment • Sophie Ehrlich — EIT Health • Anjany Sekuboyina — Bonsescreen • Andreu M. Climent — Corify Care • Andreas Schriefl — eMurmur • Jordina Arcal Cunillera — MJN Neuroserveis Light at the End of the Tunnel in Medtech Financing • Nick Pachuda — Neovate, Peptilogics • Martin Omid A. — Anthro Ventures • Anita Watkins — REX Health Ventures • Sean Morris — Cultivation Capital • Eman Namati — SpectraWAVE Building Syndicates of Cross-Border Investors in Medtech Companies • Ashley Seehusen — SANTÉ • Robert J. Krummen — Vektor Medical • C David Adair MD, MBA, FACOG, FASH, C-EFM — Solas BioVentures • Dr. Luc Marengere — TVM Capital Life Science • Alexander Goemans — Xeltis The Art and Science of Cross-Border Business Development and Licensing • Ajay Nair — The Mullings Group • Eliane Schutte — Xeltis • Pieter Wijffels — NLC Health Ventures • Jeffrey Sirek — PRIA Healthcare • Dr Sabine Kapasi — United Nations Day 2 will feature another 13 Keynotes, Panels, and Fireside Chats sessions.

You read that right—LSI Europe '25 is heading to London! Mark your calendars for September 7th - 11th, 2025, as we bring the event to the heart of the city. Registration is now open. Staying true to our ethos, LSI Europe '25 will not be held in a bustling convention center. We've selected the JW Marriott Grosvenor House London in Mayfair on Park Lane—a 5-star property uniquely suited to accommodate our event's growth without compromising the world-class experience you expect from LSI. The venue's Great Room has been the backdrop for exclusive events since 1929, welcoming royalty, presidents, actors, and musicians alike. Guests will enjoy modern luxury, inspired service, and award-winning cuisine, where senior executives can do real business. Get in touch with our team today to take advantage of our best rates and secure your hotel room onsite.